The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension. [electronic resource]
Producer: 20080110Description: 11C-16C p. digitalISSN:- 1916-7075
- Acrylates -- administration & dosage
- Administration, Oral
- Age Factors
- Aged
- Aged, 80 and over
- Angiotensin II Type 1 Receptor Blockers -- administration & dosage
- Blood Pressure -- drug effects
- Blood Pressure Determination
- Canada
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Hypertension -- diagnosis
- Imidazoles -- administration & dosage
- Male
- Middle Aged
- Probability
- Reference Values
- Severity of Illness Index
- Systole -- drug effects
- Thiophenes -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.